SCHEMBL7104094

SCHEMBL7104094

O=C(COc1ccccc1)c1ccccc1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.57
HPGD P15428 2/20 0.55
HSD17B10 Q99714 1/20 0.55
RAB9A P51151 3/20 0.50
ALDH1A1 P00352 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
NPSR1 Q6W5P4 2/20 0.50
MAPT P10636 2/20 0.50
KDM4E B2RXH2 2/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
HMGB1 P09429 1/20 0.50
CA4 P22748 1/20 0.50
CA6 P23280 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
NAPRT Q6XQN6 1/20 0.50
CA14 Q9ULX7 1/20 0.50
KMT2A Q03164 6/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15079428 0.93 PNLIP (0.55) ALOX15HPGDHSD17B10RAB9ASMN1; SMN2
SCHEMBL15079897 0.90 MAPT (0.57) ALOX15HPGDHSD17B10RAB9AALDH1A1
SCHEMBL15079772 0.89 PKM (0.56) HPGDHSD17B10RAB9AALDH1A1SMN1; SMN2
SCHEMBL15079898 0.86 NPC1 (0.66) ALOX15HPGDRAB9AALDH1A1SMN1; SMN2
SCHEMBL15079381 0.86 RAB9A (0.68) RAB9AALDH1A1SMN1; SMN2NPSR1MAPT
SCHEMBL15079875 0.86 KMT2A (0.65) HPGDRAB9AALDH1A1SMN1; SMN2NPSR1
SCHEMBL15079411 0.86 KMT2A (0.62) ALOX15HPGDHSD17B10RAB9AALDH1A1
SCHEMBL15079915 0.86 KMT2A (0.59) HPGDHSD17B10RAB9AALDH1A1SMN1; SMN2
SCHEMBL15079421 0.86 RAB9A (0.46) ALOX15HPGDHSD17B10RAB9AALDH1A1
SCHEMBL15079369 0.84 KDM4E (0.52) HSD17B10RAB9AALDH1A1SMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9629822-B2 Flavonoid based antiviral targets UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2017-04-25 US disclosed
US-20150209323-A1 FLAVONOID BASED ANTIVIRAL TARGETS UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, (US) 2015-07-30 US disclosed
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS DIVERCHIM (FR) 2015-01-01 US disclosed
WO-2014047551-A1 FLAVONOID BASED ANTIVIRAL TARGETS UNIVERSITY OF CENTER FLORIDA RESEARCH FOUNDATION, INC. (US) 2014-03-27 WO disclosed
EP-0744463-B1 Liquid peracid precursor colloidal dispersions: oil-core vesicles CLOROX CO (US) 2003-01-22 EP disclosed
EP-0744464-B1 Liquid peracid precursor colloidal dispersions: liquid crystals CLOROX CO (US) 2003-01-22 EP disclosed
EP-0744462-B1 Liquid peracid precursor colloidal dispersions: microemulsions CLOROX CO (US) 2002-08-07 EP disclosed
US-5977044-A PARTITIONED CONTAINER PETERSON DAVID (US) 1999-11-02 US disclosed
US-5954998-A BLEACH DELIVERY ACTIVATORS THE CLOROX COMPANY (US) 1999-09-21 US disclosed
US-5877136-A Liquid peracid precursor colloidal dispersions: Liquid crystals THE CLOROX COMPANY (US) 1999-03-02 US disclosed
US-5877137-A DIVIDED CONTAINER FOR SUPPLYING BLEACH AND EMULSIFIER THE CLOROX COMPANY (US) 1999-03-02 US disclosed
US-5792385-A STORAGE STABLE THE CLOROX COMPANY (US) 1998-08-11 US disclosed
US-5776877-A CONTAINER THE CLOROX COMPANY (US) 1998-07-07 US disclosed
US-5681805-A STABLE LIQUID BLEACH, CLEANING COMPOUND THE CLOROX COMPANY (US) 1997-10-28 US disclosed
EP-0744463-A2 Liquid peracid precursor colloidal dispersions: oil-core vesicles The Clorox Company (US) 1996-11-27 EP disclosed
EP-0744462-A2 Liquid peracid precursor colloidal dispersions: microemulsions The Clorox Company (US) 1996-11-27 EP disclosed
EP-0744464-A2 Liquid peracid precursor colloidal dispersions: liquid crystals The Clorox Company (US) 1996-11-27 EP disclosed
EP-0744465-A2 Liquid peracid precursor colloidal dispersions: Macroemulsions The Clorox Company (US) 1996-11-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150209323-A1 FLAVONOID BASED ANTIVIRAL TARGETS RBM28, MAVS, HAVCR2 ALOX15 3312/4885HPGD 3961/4885HSD17B10 3877/4885
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS ARG1, TYR, NOS1 ALOX15 111/4885HPGD 84/4885HSD17B10 203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.